콘텐츠로 건너뛰기
주식/증권 📈 긍정적

REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?

요약

Regeneron's Eylea HD and Dupixent strength are fueling growth, while oncology gains and pipeline progress support its outlook.